Fetal hydantoin syndrome
Summary of Fetal hydantoin syndrome
Fetal hydantoin syndrome, also called fetal dilantin syndrome is a group of defects caused to the developing fetus by exposure to the teratogenic effects of phenytoin or carbamazepine. Dilantin is the brand name of the drug phenytoin sodium in the United States, commonly used in the treatment of epilepsy.
Videos
Notes
Pathology
Reproductive system
Male and female reproductive system disorders
Male reproductive system disorders
Female reproductive system disorders
Amenorrhea
Ovarian cyst
Premature ovarian failure
Polycystic ovary syndrome
Ovarian torsion
Krukenberg tumor
Sex cord-gonadal stromal tumor
Surface epithelial-stromal tumor
Germ cell ovarian tumor
Uterine fibroid
Endometriosis
Endometritis
Endometrial hyperplasia
Endometrial cancer
Choriocarcinoma
Cervical cancer
Pelvic inflammatory disease
Urethritis
Female sexual interest and arousal disorder
Orgasmic dysfunction
Genito-pelvic pain and penetration disorder
Mastitis
Fibrocystic breast changes
Intraductal papilloma
Phyllodes tumor
Paget disease of the breast
Breast cancer
Hyperemesis gravidarum
Gestational hypertension
Preeclampsia & eclampsia
Gestational diabetes
Cervical incompetence
Placenta previa
Placenta accreta
Placental abruption
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital cytomegalovirus (NORD)
Congenital syphilis
Neonatal conjunctivitis
Neonatal herpes simplex
Congenital rubella syndrome
Neonatal sepsis
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Ectopic pregnancy
Fetal hydantoin syndrome
Fetal alcohol syndrome
Reproductive system pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Amenorrhea: Pathology Review
Testicular and scrotal conditions: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
HIV and AIDS: Pathology review
AssessmentsFetal hydantoin syndrome
Fetal hydantoin syndrome
Flashcards
0 / 7 complete
Questions
1 / 1 complete
Flashcards
Fetal hydantoin syndrome
7 flashcards
Questions
USMLE® Step 1 style questions USMLE
1 questions
USMLE® Step 2 style questions USMLE
1 questions
Preview
A 2-week-old newborn is brought into the pediatrician's office for his first well-child visit. During the appointment, the mother is concerned that he is quite small, even for a baby, and that his head seems especially small. On physical examination the newborn is found to be below the 5th percentile for both length and head circumference. The pediatrician asks the mother if she drank during pregnancy which she denies. She then reveals that she has epilepsy and was taking her medication at regular dose throughout the pregnancy. Based on the newborn's presentation, which of the following drugs is most likely to cause his condition?
Memory Anchors and Partner Content
External References
External Links
Fetal hydantoin syndrome exam links
Feedback